Pharmacokinetics of intravenous immunoglobulin: a systematic review.
about
The Production Processes and Biological Effects of Intravenous ImmunoglobulinPopulation pharmacokinetic data analysis of three phase I studies of matuzumab, a humanised anti-EGFR monoclonal antibody in clinical cancer developmentThe role of polyclonal intravenous immunoglobulin in treating HIV-infected children with severe bacterial infections: a retrospective cohort study.II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis.A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories.Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspectiveDrug removal by plasmapheresis: an evidence-based review.Does intravenous immunoglobulin therapy prolong immunodeficiency in transient hypogammaglobulinemia of infancy?Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis.A review on guidelines for management and treatment of common variable immunodeficiency.Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options.Nebulization as a delivery method for mAbs in respiratory diseases.Hypogammaglobulinemia in infants receiving chronic peritoneal dialysis.A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency.Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients.Lack of racial differences in the pharmacokinetics of subcutaneous golimumab in healthy Japanese and Caucasian male subjects.An update on treatment strategies for common variable immunodeficiency.DNA-scaffolded multivalent ligands to modulate cell function.Population pharmacokinetics of infliximab in patients with ankylosing spondylitis.Comparison of Weight-Based Dosing Strategies for Intravenous Immunoglobulin in Patients with Hematologic Malignancies.Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study.Pharmacokinetics and Pharmacodynamics of Intravenous Immunoglobulin G Maintenance Therapy in Chronic Immune-mediated Neuropathies.An exploratory trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis: a preliminary multicenter report.Population pharmacokinetic analysis of tocilizumab in patients with rheumatoid arthritis.Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications.
P2860
Q26752540-10261EFE-1B81-4B25-8155-08833E066CC6Q31148686-D6262A61-CCF8-402E-B972-E0023D049ABDQ33371407-8C5BAF5B-6F77-4F7A-8666-FD8DDEF2178CQ33692418-592B8D52-3832-4F8C-95CD-B5F87C65105BQ34576320-46ED0630-B8A5-46DD-A9A4-5744F83E00BFQ35169322-11FF02F0-30A4-4114-99CD-F97C7B8CF511Q36646072-04DE8653-948D-4F44-AD55-903E089ECF06Q36982684-89E6391A-4747-4DD1-9890-8797A6621840Q37266580-7A1EE8CB-AE80-419A-909C-CB0C9CA7E430Q37364113-4285638B-E6A6-44F8-A5AC-BB8DBC8EBC87Q38021422-C7FF9F57-4B1A-4AC5-8D51-BB6BB1E4ABCFQ38111423-18C82BAA-B327-4F37-AE4C-E74E89C80554Q38206175-E2B2FB03-4AE4-4EC9-BF53-C6707487D72FQ38306677-70D3475F-AD1D-47AB-998C-65B83656CFB6Q39310435-D0C48A17-CCCF-44E5-B72E-DD933B77CBA8Q40133456-8357E66F-B7F0-407C-AF36-9676644C5F8AQ41322794-04FD4049-7502-4E26-8B1D-AF107CF46FCCQ43172644-F6355993-5445-4DC0-9F46-0FA59BB0A1F5Q44024797-B271934F-0B19-4125-B7C9-0E9C41E4290DQ46196202-A7B95F6E-6318-47A8-988C-18C3433C6A0EQ46653850-56C235A6-EC2A-4B18-90C9-26DFA4A13C8AQ47182455-2017D581-A4D0-43DA-8DE2-6F5677D93706Q47289931-148A63EC-3AB9-4E8D-9D84-84224F7252C1Q50748736-14E03A50-E101-4A11-B321-BEA4859DAFA3Q51428039-4556BF28-1431-409F-AF05-7F3A08CC4B9CQ51726885-5FD23B1E-0BCE-43B1-A0A3-726C866ECD22Q53240561-E14371F5-3960-434C-86FE-8053D9191E52
P2860
Pharmacokinetics of intravenous immunoglobulin: a systematic review.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pharmacokinetics of intravenous immunoglobulin: a systematic review.
@ast
Pharmacokinetics of intravenous immunoglobulin: a systematic review.
@en
type
label
Pharmacokinetics of intravenous immunoglobulin: a systematic review.
@ast
Pharmacokinetics of intravenous immunoglobulin: a systematic review.
@en
prefLabel
Pharmacokinetics of intravenous immunoglobulin: a systematic review.
@ast
Pharmacokinetics of intravenous immunoglobulin: a systematic review.
@en
P2860
P31
P356
P1433
P1476
Pharmacokinetics of intravenous immunoglobulin: a systematic review
@en
P2093
Tamar Koleba
P2860
P304
P356
10.1592/PHCO.26.6.813
P407
P577
2006-06-01T00:00:00Z